Applied Therapeutics, Inc.
APLT
$0.4101
-$0.0309-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -187.31M | -161.09M | -193.56M | -119.76M | -96.51M |
| Total Depreciation and Amortization | 352.00K | 366.00K | 360.00K | 354.00K | 462.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.38M | 93.59M | 129.49M | 65.68M | 45.12M |
| Change in Net Operating Assets | -1.26M | -6.10M | -3.38M | -1.44M | -3.13M |
| Cash from Operations | -81.84M | -73.24M | -67.09M | -55.17M | -54.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 13.87M | 6.97M |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 13.87M | 6.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -776.00K | -1.24M | -1.55M | -1.86M | -2.33M |
| Issuance of Common Stock | 145.72M | 162.75M | 190.66M | 74.85M | 44.94M |
| Repurchase of Common Stock | -1.69M | -1.69M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 1.55M | 1.55M | 1.55M |
| Cash from Financing | 143.25M | 159.82M | 190.66M | 74.54M | 44.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.41M | 86.58M | 123.57M | 33.24M | -2.93M |
